Brennan Daniel J.'s Form 4 filing
Boston Scientific Corp (BSX) · filed May 23, 2024
- Accession no.
- 0001225208-24-006325
- Filed
- May 23, 2024
- Trade date
- May 22-23, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $8.47M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brennan Daniel J.CIK 0001595612 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | Common Stock | MOption exerciseAcquired | +16,863 | $24.55 | +$413,986.65 | 288,405 | Direct | |
| May 22, 2024 | Common Stock | MOption exerciseAcquired | +16,863 | $17.26 | +$291,055.38 | 305,268 | Direct | |
| May 22, 2024 | Common Stock | MOption exerciseAcquired | +15,642 | $27.09 | +$423,741.78 | 320,910 | Direct | |
| May 22, 2024 | Common Stock | MOption exerciseAcquired | +15,086 | $16.31 | +$246,052.66 | 335,996 | Direct | |
| May 22, 2024 | Common Stock | SSaleDisposed | −64,454 | $75.91F2 | −$4,892,703.14 | 271,542 | Direct | |
| May 23, 2024 | Common Stock | SSaleDisposed | −47,621 | $75.11F3 | −$3,576,813.31 | 223,921 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2024 | Common Stock | MOption exerciseDisposed | −15,642 | $0.00 | $0 | 46,927 | Direct | |
| May 22, 2024 | Common Stock | MOption exerciseDisposed | −16,863 | $0.00 | $0 | 16,865 | Direct | |
| May 22, 2024 | Common Stock | MOption exerciseDisposed | −15,086 | $0.00 | $0 | 15,087 | Direct | |
| May 22, 2024 | Common Stock | MOption exerciseDisposed | −16,863 | $0.00 | $0 | 55,600 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.512 to $76.22, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.86 to $75.48, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.